Dementia awareness, resident protection at center of 2 bills before lawmakers
By
Kimberly Bonvissuto
Feb 27, 2024
Raising dementia awareness is the goal of separate bills under consideration by lawmakers in Ohio and Georgia.
Number of people with Alzheimer’s to double by 2060, CDC predicts
By
Lois A. Bowers
Sep 21, 2018
The number of people in the United States with Alzheimer’s disease and related dementias is expected to double by 2060, according to a study published Thursday by the Centers for Disease Control and...
Behavioral health-memory care model serves increasing needs in senior living
By
Kimberly Bonvissuto
Aug 16, 2023
Cascade Senior Living Servicesgot creative by pursuing uncommon contracts and specialty partnerships to serve people living with significant mental health or dementia diagnoses.
CCAs can lower person-centered dementia care costs
By
Lois A. Bowers
Apr 10, 2016
Care coordinator assistants can be a low-cost way to facilitate person-centered care for those with dementia and their caregivers, according to a new study.
Omnibus bill includes $3.1 billion for dementia research
By
Lois A. Bowers
Dec 22, 2020
The $1.4 trillion appropriations omnibus spending bill advanced by congressional leaders on Monday includes an increase of more than $300 million in funding for dementia research at the National Institutes...
Master Plan for Aging adds dementia screening tool for providers
By
Lois A. Bowers
Apr 17, 2023
Primary care providers in the country’s most populous state have a new screening tool to help them identify cognitive decline in older adults and determine next steps.
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Pharmaceutical company to pay $96 million to settle claims of promoting unapproved use of drug for dementia...
By
Lois A. Bowers
Sep 27, 2019
Pharmaceutical company Avanir has agreed to pay $96 million to resolve federal False Claims Act allegations that it paid kickbacks and marketed the drug Nuedexta in long-term care communities for the off-label...
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
NIH requests additional $321M for Alzheimer’s, dementia research
By
Kimberly Bonvissuto
Aug 02, 2022
The National Institutes of Health has requested an additional $321 million in fiscal year 2024 for research into Alzheimer’s and other dementias.